Manila Times Business
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
Data from the RALLY-MF trial of DISC-0974 in patients with myelofibrosis (MF) and anemia demonstrate meaningful, durable overall anemia responses across all patient subgroups, regardless of baseline transfusion status or concomitant JAK inhibitor useUpdated data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP) show sustained reductions in protoporphyrin IX (PPIX), significant improvement in light tolerance measures, and favorable longer-term safety
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
1h ago
What Is XM Partner Code Y8MH4 and Why Is It Growing?
1h ago
Eight Saints Launches Firm Intentions, a Clean Anti-Aging Neck Cream, Targeting Skincare's Most Overlooked Area
1h ago
Limitless Sky Launches empty-legs-flights.com - The World’s Most Comprehensive Real-Time Empty Leg Private Jet Platform
1h ago